UC Santa Cruz Live in Silicon Valley: The Next Generation of Digital Health


Innovations in healthcare are riding a wave of new, powerful tools, from artificial intelligence to personalized medicine. Our evening seminar will highlight examples of future technologies and question their potential effectiveness in the challenging US healthcare market. The panel will include perspectives from inventors, investors, entrepreneurs, and academics.


David Deamer, professor at UC Santa Cruz, invented the central technology licensed by Oxford Nanopore Technology (ONT) for analyzing DNA, RNA, proteins, and small molecules.

Kimberly MacPherson is the Executive Director of Health Management at the Haas School of Business and faculty in Health Policy and Management at the U.C. Berkeley School of Public Health. She is also the Co-Director for the Berkeley Center for Health Technology (BCHT).

Greg Yap, partner at Menlo Ventures, focuses on health, medical, and life science technology investments. Prior to joining Menlo, Greg served as entrepreneur-in-residence at Illumina Ventures; CEO and co-founder of PyrAmes, a digital health company; and CEO and co-founder of Biodesy, a protein analysis company.

Sam De Brouwer is cofounder at doc.ai, a blockchain conversational AI platform that performs deep learning computations on quantified biology to develop predictive analytics and personal health insights.

Location details: 

UC Santa Cruz Silicon Valley Campus
3175 Bowers Avenue
Santa Clara, CA 95054

Admission Required
Admission details: 

$10 ticket* (ticket price will increase to $15 after February 6)
*This event is open to the public and free to UC Santa Cruz students with valid ID.

Event dates: 
02/13/2018 - 6:00pm